Obezita 120mg 10 Capsules

Babies: It is not applicable for babies. Lactating mothers: It is safe to use during breastfeeding.
Human studies suggest that the drug does not pass into the breastmilk and is not harmful to the baby. Pregnancy: It is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects on the developing baby. Driving: This medication does not affect the ability to drive.
Alcohol: It does not cause any harmful side effects. Liver: Safe if prescribed. Kidney: Safe if prescribed..

Abdominal pain Fat in stool Flatus with discharge Oily spotting Diarrhoea Abdominal cramp Flatulence Soft stools Unusual tiredness and weakness Trouble sleeping.

Obezita tablet is a lipase inhibitor. It works in the stomach and small intestine by blocking the absorption of fat from food which is responsible for the breakdown of fat..

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• Obezita tablet is a lipase inhibitor used to aid weight loss in obese individuals. • Take this tablet along with regular physical activity and healthy meals. • Take it during or up to 1 hour after each meal. • Skip your dose if you miss a meal or if your diet contains no fat. • Do not take this medicine for longer than six months. If you have been unable to lose weight after 12 weeks of taking this medicine, you should stop taking it and consult your doctor. • When taking the obezita tablet, recommend the patient to take a multivitamin supplement containing a, d and k..

Major • Obezita + Abacavir: Concurrent use of both drugs may result in loss of virological control • Obezita + Acenocoumarol: Concurrent use of both drugs may result in an increased risk of bleeding • Obezita + Carbamazepine: Concurrent use of both drugs may result in the reduced anticonvulsant effect • Obezita + Clorazepate: Concurrent use of both drugs may result in the reduced anticonvulsant effect • Obezita + Dalteparin: Concurrent use of both drugs may result in an increased risk of bleeding • Obezita + Heparin: Concurrent use of both drugs may result in an increased risk of bleeding • Obezita + Lamivudine: Concurrent use of both drugs may result in loss of virological control • Obezita + Pregabalin: Concurrent use of both drugs may result in the reduced anticonvulsant effect • Obezita + Valproate sodium: Concurrent use of both drugs may result in the reduced anticonvulsant effect • Obezita + Vigabatrin: Concurrent use of both drugs may result in the reduced anticonvulsant effect Moderate • Obezita + Levothyroxine: Concurrent use of both drugs may result in reduced efficacy of levothyroxine • Obezita +Linoleic acid: Concurrent use of both drugs may result in decreased absorption of linoleic acid.